AIDS-Defining Illnesses
AIDS-defining illnesses are specific conditions that, when present in a person with HIV infection, establish the diagnosis of AIDS, including aggressive non-Hodgkin's lymphoma, Kaposi sarcoma, and invasive cervical cancer, along with 20 other clinical conditions defined by the CDC. 1
Definition and Classification
AIDS is diagnosed in HIV-infected individuals who meet one of the following criteria:
- CD4+ T-lymphocyte count less than 200 cells/μL
- CD4+ T-lymphocyte percentage of total lymphocytes less than 14%
- Presence of one or more AIDS-defining clinical conditions 1
The 23 Clinical Conditions That Define AIDS
Cancers
- Kaposi sarcoma (caused by HHV-8/KSHV) 2
- Aggressive non-Hodgkin's lymphoma (including primary CNS lymphoma)
- Invasive cervical cancer 1
Opportunistic Infections
Fungal Infections
- Pneumocystis jiroveci (formerly carinii) pneumonia (PCP)
- Candidiasis of bronchi, trachea, lungs, or esophagus
- Extrapulmonary cryptococcosis
- Disseminated or extrapulmonary histoplasmosis
- Chronic intestinal cryptosporidiosis
- Disseminated or extrapulmonary coccidioidomycosis
Viral Infections
- Cytomegalovirus disease (other than liver, spleen, or nodes)
- Cytomegalovirus retinitis (with vision loss)
- Chronic herpes simplex ulcers (>1 month duration)
- Progressive multifocal leukoencephalopathy
Bacterial Infections
- Mycobacterium tuberculosis (pulmonary or extrapulmonary)
- Mycobacterium avium complex or Mycobacterium kansasii (disseminated or extrapulmonary)
- Other species of Mycobacterium (disseminated or extrapulmonary)
- Recurrent bacterial pneumonia (≥2 episodes in 12 months)
- Recurrent Salmonella septicemia
Protozoal Infections
- Toxoplasmosis of the brain
- Isosporiasis with diarrhea (>1 month duration)
Other Conditions
- HIV wasting syndrome
- HIV encephalopathy 1
Epidemiology and Incidence
The incidence of AIDS-defining illnesses varies by CD4 count level:
- At CD4 counts >200 cells/μL: Tuberculosis, recurrent bacterial pneumonia, and Kaposi sarcoma may occur
- At CD4 counts 50-200 cells/μL: PCP, esophageal candidiasis, and brain toxoplasmosis become more common
- At CD4 counts <50 cells/μL: Cytomegalovirus disease and Mycobacterium avium complex infection predominate 3
Impact of Antiretroviral Therapy
The introduction of highly active antiretroviral therapy (HAART) has dramatically changed the landscape of AIDS-defining illnesses:
- AIDS-defining cancers have declined significantly (Kaposi sarcoma by up to 90%) 1
- The 5-year survival rate for patients with AIDS-related Kaposi sarcoma improved from 12.1% in the pre-ART era to as high as 88% currently 2
- Non-AIDS-defining cancers now represent an increasing proportion of malignancies in people living with HIV 1
Clinical Pearls
- AIDS-defining illnesses may present atypically in HIV-infected patients, especially with advanced immunosuppression
- Multiple AIDS-defining conditions often coexist in the same patient
- Non-malignant causes of lymphadenopathy should be considered in people living with HIV 1
- The risk of developing opportunistic infections increases progressively as CD4 counts fall below 200 cells/mm³ 4
Prevention
- Early HIV diagnosis and prompt initiation of antiretroviral therapy is the most effective strategy to prevent AIDS-defining illnesses
- Prophylaxis against common opportunistic infections (particularly PCP and toxoplasmosis) is indicated at specific CD4 thresholds
- Regular monitoring of CD4 counts helps identify patients at risk for specific opportunistic infections 1